| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.1 |